Correlation Between ImageJ and Conventional Manual Scoring Methods for Programmed Death-Ligand 1 Immuno-Histochemically Stained Sections.
Rand Suleiman Al TaherManal A AbbasKhalid HalahlehMaher A SughayerPublished in: Technology in cancer research & treatment (2024)
Background: One of the most frequently used methods for quantifying PD-L1 (programmed cell death-ligand 1) expression in tumor tissue is IHC (immunohistochemistry). This may predict the patient's response to anti-PD1/PD-L1 therapy in cancer. Methods: ImageJ software was used to score IHC-stained sections for PD-L1 and compare the results with the conventional manual method. Results: In diffuse large B cell lymphoma, no significant difference between the scores obtained by the conventional method and ImageJ scores obtained using the option "RGB" or "Brightness/Contrast." On the other hand, a significant difference was found between the conventional and HSB scoring methods. ImageJ faced some challenges in analyzing head and neck squamous cell carcinoma tissues because of tissue heterogenicity. A significant difference was found between the conventional and ImageJ scores using HSB or RGB but not with the "Brightness/Contrast" option. Scores obtained by ImageJ analysis after taking images using 20 × objective lens gave significantly higher readings compared to 40 × magnification. A significant difference between camera-captured images' scores and scanner whole slide images' scores was observed. Conclusion: ImageJ can be used to score homogeneous tissues. In the case of highly heterogeneous tissues, it is advised to use the conventional method rather than ImageJ scoring.
Keyphrases
- diffuse large b cell lymphoma
- convolutional neural network
- deep learning
- gene expression
- magnetic resonance
- optical coherence tomography
- epstein barr virus
- poor prognosis
- magnetic resonance imaging
- squamous cell carcinoma
- stem cells
- computed tomography
- mass spectrometry
- bone marrow
- high resolution
- mesenchymal stem cells
- young adults
- contrast enhanced
- lymph node metastasis
- replacement therapy
- childhood cancer